摘要
目的探讨肌酸激酶同工酶(CK-MB)质量与活性的测定在急性心肌梗死(acute myocardialinfarction,AMI)早期诊断的价值。方法应用电化学发光法与酶免疫抑制法分别测定36例AMI患者、38例心绞痛患者(angina pectoris,AP)及30例正常对照组CK-MB的质量与活性。结果 AMI组患者CK-MB质量与活性达到峰值的时间完全相同,但CK-MB质量的升高倍数(18倍)明显高于CK-MB活性(7倍);AMI组患者CK-MB的质量与活性均明显高于AP组和正常对照组,差异有统计学意义(P<0.01),AP组的CK-MB活性高于正常对照组,差异有统计学意义(P<0.01),而AP组CK-MB质量与正常对照组比较,差异无统计学意义(P>0.05)。结论 CK-MB的质量与活性在急性心肌梗死早期诊断中都较敏感,但CK-MB质量的测定在对抗干扰因素方面明显好于CK-MB活性的测定。
Objective To evaluate the early diagnosis value of the determination of serum CK-MB mass and activity in acute myocardial infarction(AMI).Methods The serum CK-MB mass and activity were determined by electrochemiluminescence and immunosupperssion in 36 patients with AMI,38 cases of patients with angina pectoris(AP)and 30 cases of normal control.Results The peak time of CK-MB mass and activity in AMI patients was exactly the same,but the rise of CK-MB mass ratio(18 times)obviously higher than CK-MB activity(7times);CK-MB mass and activity in AMI patients were significantly higher than that of AP group and normal control group,the difference was statistically significant(P〈0.01).CK-MB activity in AP group was higher than that of normal control group,the difference was statistically significant(P〈0.01),the difference of CK-MB mass in AP group and normal control group was not statistically significant(P〈0.05).Conclusion CK-MB mass and activity in the early diagnosis of AMI are very sensitive,but the determination of CK-MB mass in the fight against interference factors was significantly better than CK-MB activity.
出处
《成都医学院学报》
CAS
2012年第1期105-107,共3页
Journal of Chengdu Medical College
基金
中国高校医学期刊临床专项资金项目(NO11221511)